David Quigley
CIK: 0002098754
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRVO
CervoMed Inc.
Director
Discretionary Trading P&L
Holdings
About Quigley David
Quigley David (SEC CIK 0002098754) files insider reports with the SEC as Director of CervoMed Inc. (CRVO).
Signal8 holds 3 ownership filings by Quigley David (1 Form 3, 2 Form 4), filed between Dec 5, 2025 and Jun 10, 2026. Those filings report 2 transactions, from Oct 27, 2025 to Jun 8, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Quigley David's filings is in BOSTON, MA.
Recent filings by Quigley David
Other insiders filing for CervoMed Inc. (CRVO)
- Blackburn Kelly, EVP, Clinical Development
- De Rosch Mark, EVP, RA and GA and PgM
- Winton Matthew, Chief Commercial and Business
- BOGER JOSHUA S, Director
- ZAVRL FRANK, Director
- Sabbagh Marwan, Director